الفهرس 
Introduction and Aim of the WorkOnly 14 pages are availabe for public view
 |  | from | 96 |  |  |
| | | from | 96 | | |
Abstract
In conclusion, the prevalence of GDM is raising worldwide parallel to the increment in the prevalence of obesity and T2DM.
GDM is a condition that should be treated aggressively and it is a problem that affects a significant number of women during pregnancy and is associated with maternal and neonatal adverse outcomes..
Increasing age, BMI, weight, martial period and positive family history for diabetes are highly prone to gestational diabetes mellitus and those women has to be considered as high risk group.
Regardless of risk factors, early screening before 24th week of gestation, for gestational diabetes mellitus is strictly recommended.
Maintaining adequate blood glucose levels in GDM reduces morbidity for both mother and baby.
Treatment of GDM consists of diet and exercise. Insulin should be initiated if the initial measures fail to achieve glycemic goals. Insulin analogs are associated with less risk of hypoglycemia, and may provide better glycemic control than human insulin.
Increased awareness of the magnitude and timing of the risk of type 2 diabetes after gestational diabetes among patients and clinicians could provide an opportunity to test and use dietary, lifestyle, and pharmacological interventions that might prevent or delay the onset of type 2 diabetes in affected women.
There is still a lack of uniform strategies for screening and diagnosing GDM worldwide. Therefore, there is a need to standardize the screening and the diagnostic criteria for GDM globally.